Workplace Violence and the Mental Health of Public Health Workers During COVID-19.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
03 2023
Historique:
received: 22 06 2022
revised: 06 10 2022
accepted: 10 10 2022
pubmed: 5 12 2022
medline: 25 2 2023
entrez: 4 12 2022
Statut: ppublish

Résumé

During the COVID-19 pandemic, public health workers were at an increased risk for violence and harassment due to their public health work and experienced adverse mental health conditions. This article quantifies the prevalence of job-related threats, harassment, and discrimination against public health workers and measures the association of these incidents with mental health symptoms during the COVID-19 pandemic. A nonprobability convenience sample of state, local, and tribal public health workers completed a self-administered, online survey in April 2021. The survey link was emailed to members of national public health associations and included questions on workplace violence, demographics, workplace factors, and mental health symptoms. Mental health symptoms were measured using standardized, validated tools to assess depression, anxiety, post-traumatic stress disorder, and suicidal ideation. Multivariable Poisson models calculated adjusted prevalence ratios of mental health symptoms, with workplace violence as the primary risk factor. Analyses were conducted in 2021-2022. Experiencing any type or combination of workplace violence was significantly associated with an increased likelihood of reporting depression symptoms (prevalence ratio=1.21, 95% CI=1.15, 1.27), anxiety (prevalence ratio=1.21, 95% CI=1.15, 1.27), post-traumatic stress disorder (prevalence ratio=1.31, 95% CI=1.25, 1.37), and suicidal ideation (prevalence ratio=1.26, 95% CI=1.14, 1.38), after adjusting for confounders. A dose‒response relationship was found between the number of workplace violence events experienced by a public health worker and the likelihood of reporting mental health symptoms. Violence targeted at the public health workforce is detrimental to workers and their communities. Ongoing training, workplace support, and increased communication after a workplace violence incident may be helpful. Efforts to strengthen public health capacities and support the public health workforce are also needed.

Identifiants

pubmed: 36464557
pii: S0749-3797(22)00507-4
doi: 10.1016/j.amepre.2022.10.004
pmc: PMC9659550
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

315-325

Informations de copyright

Published by Elsevier Inc.

Auteurs

Hope M Tiesman (HM)

Analysis and Field Evaluations Branch, Division of Safety Research, National Institute for Occupational Safety and Health, Morgantown, West Virginia. Electronic address: htiesman@cdc.gov.

Scott A Hendricks (SA)

Analysis and Field Evaluations Branch, Division of Safety Research, National Institute for Occupational Safety and Health, Morgantown, West Virginia.

Douglas M Wiegand (DM)

Hazard Evaluations & Technical Assistance Branch, Division of Field Studies & Engineering, National Institute for Occupational Safety and Health, Cincinnati, Ohio.

Barbara Lopes-Cardozo (B)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Carol Y Rao (CY)

Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Libby Horter (L)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia; Goldbelt C6, Chesapeake, Virginia.

Charles E Rose (CE)

National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia.

Ramona Byrkit (R)

COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH